These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31579066)
1. MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β-catenin signaling pathway. Wang Q; Geng F; Zhou H; Chen Y; Du J; Zhang X; Song D; Zhao H Oncol Lett; 2019 Oct; 18(4):4294-4307. PubMed ID: 31579066 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells. Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211 [TBL] [Abstract][Full Text] [Related]
3. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling. Geng F; Jiang Z; Song X; Zhou H; Zhao H Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479 [TBL] [Abstract][Full Text] [Related]
4. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. Vesel M; Rapp J; Feller D; Kiss E; Jaromi L; Meggyes M; Miskei G; Duga B; Smuk G; Laszlo T; Karner I; Pongracz JE Respir Res; 2017 Mar; 18(1):52. PubMed ID: 28340578 [TBL] [Abstract][Full Text] [Related]
5. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells. Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138 [TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line. Li A; Song J; Lai Q; Liu B; Wang H; Xu Y; Feng X; Sun X; Du Z Int J Exp Pathol; 2016 Dec; 97(6):412-421. PubMed ID: 27995666 [TBL] [Abstract][Full Text] [Related]
7. The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line. Jin C; Song P; Pang J Oncol Lett; 2019 Oct; 18(4):3845-3856. PubMed ID: 31579410 [TBL] [Abstract][Full Text] [Related]
8. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells. Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719 [TBL] [Abstract][Full Text] [Related]
9. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells]. He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289 [TBL] [Abstract][Full Text] [Related]
10. Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells. He J; Shi J; Zhang K; Xue J; Li J; Yang J; Chen J; Wei J; Ren H; Liu X Mol Med Rep; 2017 Apr; 15(4):1693-1701. PubMed ID: 28259951 [TBL] [Abstract][Full Text] [Related]
11. An inverse interaction between Zhang Y; Yuan Y; Li Y; Zhang P; Chen P; Sun S Epigenetics; 2019 Oct; 14(10):949-960. PubMed ID: 31144606 [No Abstract] [Full Text] [Related]
12. [Role of SOX4 on DDP Resistance in Non-small Cell Lung Cancer Cell of A549]. Li W; Liu X; Zhang G; Zhang L Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):298-302. PubMed ID: 28532536 [TBL] [Abstract][Full Text] [Related]
13. Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma. Du H; Chen B; Jiao NL; Liu YH; Sun SY; Zhang YW Oxid Med Cell Longev; 2020; 2020():7370157. PubMed ID: 32215178 [TBL] [Abstract][Full Text] [Related]
14. Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene. Zhang J; Jiao K; Liu J; Xia Y Oncol Lett; 2018 Nov; 16(5):6071-6080. PubMed ID: 30333878 [TBL] [Abstract][Full Text] [Related]
15. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway. Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778 [TBL] [Abstract][Full Text] [Related]
16. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms. Ye MX; Zhao YL; Li Y; Miao Q; Li ZK; Ren XL; Song LQ; Yin H; Zhang J Phytomedicine; 2012 Jun; 19(8-9):779-87. PubMed ID: 22483553 [TBL] [Abstract][Full Text] [Related]
17. Reversal of galectin-1 gene silencing on resistance to cisplatin in human lung adenocarcinoma A549 cells. Zhang L; Liu X; Tang Z; Li X; Wang G Biomed Pharmacother; 2016 Oct; 83():265-270. PubMed ID: 27392028 [TBL] [Abstract][Full Text] [Related]
18. Anti-apoptotic brain and reproductive organ-expressed proteins enhance cisplatin resistance in lung cancer cells via the protein kinase B signaling pathway. Li Y; Qi K; Zu L; Wang M; Wang Y; Zhou Q Thorac Cancer; 2016 Mar; 7(2):190-8. PubMed ID: 27042221 [TBL] [Abstract][Full Text] [Related]
19. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway. Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754 [TBL] [Abstract][Full Text] [Related]
20. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model. Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]